TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma. - Gallina FT; Marinelli D; Tajè R; Visca P; Cecere FL; Landi L; Buglioni S; Forcella D; Melis E; Najmeh S; Rayes R; Cools-Lartigue J; et al. (European journal of cancer (Oxford, England : 1990), 2025)